Metformin, Ivermectin, Fluvoxamine Do Not Prevent Severe COVID-19
FRIDAY, Aug. 19, 2022 -- For patients with COVID-19 infection, metformin, ivermectin, and fluvoxamine do not prevent the occurrence of hypoxemia, an emergency department visit, hospitalization, or death, according to a study published in the Aug. 18... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 19, 2022 Category: Pharmaceuticals Source Type: news
Metformin drastically reduces COVID hospitalization
The widely available diabetes drug metformin reduced serious outcomes by more than half if started within 4 days of COVID symptoms in a large, randomized, double blind controlled trial, the University of Minnesota announced today. The results were published Aug. 18 in the New England Journal of Medicine. (Source: World Pharma News)
Source: World Pharma News - August 19, 2022 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
Three Repurposed Drugs Flop for Thwarting Severe COVID
(MedPage Today) -- Early treatment with three repurposed drugs -- metformin, ivermectin, or fluvoxamine -- did not prevent severe outcomes from COVID-19 in high-risk patients, according to a phase III randomized trial.
Among over 1,300 patients... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - August 17, 2022 Category: Endocrinology Source Type: news
Metformin Prophylaxis Cuts High-Risk Hyperglycemia From Alpelisib Metformin Prophylaxis Cuts High-Risk Hyperglycemia From Alpelisib
Taking an insulin-sensitizer a week before initiating alpelisib almost halved patients ' risk of hyperglycemia, according to a preprint study, which has not yet been peer reviewed.First Look (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 15, 2022 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Metformin Linked With Less Dementia in People With Diabetes Metformin Linked With Less Dementia in People With Diabetes
People with diabetes who started taking metformin had a significantly lower incidence of dementia compared with patients starting a sulfonylurea during 5-year follow-up of more than 112,000 US adults.First Look (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - July 28, 2022 Category: Psychiatry Tags: Diabetes & Endocrinology News Source Type: news
Could a Common Diabetes Drug Ease Bipolar Disorder?
WEDNESDAY, July 27, 2022 -- A half-century-old diabetes drug appears to help treat bipolar disorder by reversing patients ’ insulin resistance, according to a small-scale clinical trial.
Bipolar patients who responded to the drug metformin... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 27, 2022 Category: General Medicine Source Type: news
One Bout of Resistance Training Effects on Metformin Actions One Bout of Resistance Training Effects on Metformin Actions
A new study finds that one bout of full body resistance exercise has no impact on metformin ' s actions in these individuals.Medicine and Science in Sports and Exercise (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 25, 2022 Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news
People With Diabetes Are More Vulnerable to Heart Disease. How to Reduce the Risk
If you’ve been diagnosed with diabetes, know that you’ve got plenty of company. The American Diabetes Association (ADA) reports that in 2019, the most recent year for which data is available, 37.3 million adults in the U.S.—about 11.3% of the population—had the chronic condition, and that number continues to grow.
Type 1 diabetes develops when the body isn’t able to produce insulin, and Type 2 occurs when the body doesn’t use insulin correctly. Type 2 is the most common form of diabetes, and when it’s uncontrolled, a person’s blood sugar can jump to dangerous levels that requ...
Source: TIME: Health - July 20, 2022 Category: Consumer Health News Authors: Elaine K. Howley Tags: Uncategorized Disease freelance healthscienceclimate Source Type: news
Metformin Shows Potential to Prevent Macular Degeneration Metformin Shows Potential to Prevent Macular Degeneration
People prescribed the diabetes drug metformin may be less likely to develop age-related macular degeneration.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 19, 2022 Category: Endocrinology Tags: Ophthalmology News Source Type: news
Utility of support vector machine and decision tree to identify the prognosis of metformin poisoning in the United States: analysis of National Poisoning Data System - Mehrpour O, Saeedi F, Hoyte C, Goss F, Shirazi FM.
BACKGROUND: With diabetes incidence growing globally and metformin still being the first-line for its treatment, metformin's toxicity and overdose have been increasing. Hence, its mortality rate is increasing. For the first time, we aimed to study the effi... (Source: SafetyLit)
Source: SafetyLit - July 18, 2022 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
Drug safety update: Metformin and reduced vitamin B12 levels: new advice for monitoring patients at risk
Decreased vitamin B12 levels, or vitamin B12 deficiency, is now considered to be a common side effect in patients on metformin treatment, especially in those receiving a higher dose or longer treatmen (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - June 22, 2022 Category: Drugs & Pharmacology Source Type: news
ENDO: Fracture Risk Up With Insulin Compared With Metformin in T2DM
FRIDAY, June 17, 2022 -- For patients with type 2 diabetes, fracture risk is increased with insulin use compared with metformin use, according to a study presented at the annual meeting of the Endocrine Society, held from June 11 to 14 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 17, 2022 Category: Pharmaceuticals Source Type: news
Metformin Use and VTE Risk in Adults With Type 2 Diabetes Metformin Use and VTE Risk in Adults With Type 2 Diabetes
Might metformin use reduce the risk of venous thromboembolism in patients with type 2 diabetes mellitus?American Journal of Epidemiology (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - June 14, 2022 Category: Intensive Care Tags: Internal Medicine Journal Article Source Type: news
Metformin Does Not Improve Survival in High - Risk Breast Cancer
Incidence rate of invasive disease - free survival events and incidence rates for death did not differ with addition of metformin, placebo (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 6, 2022 Category: Cancer & Oncology Tags: Endocrinology, Gynecology, Oncology, Pharmacy, Journal, Source Type: news
Metformin Does Not Improve Survival in High-Risk Breast Cancer
MONDAY, June 6, 2022 -- For patients with high-risk nonmetastatic breast cancer receiving standard therapy, the addition of metformin does not improve invasive disease-free survival, according to a study published in the May 24/31 issue of the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 6, 2022 Category: Pharmaceuticals Source Type: news
